期刊
NEUROBIOLOGY OF DISEASE
卷 38, 期 1, 页码 136-143出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2010.01.012
关键词
L-DOPA; Serotonergic neurons; Dopamine release; Intracerebral microdialysis; Striatum; Substantia nigra pars reticulata; Hippocampus; Prefrontal cortex; 6-Hydroxydopamine; Parkinson's disease
资金
- Centre National de la Recherche Scientifique
- Bordeaux 2 University
Benefit and motor side effects of L-DOPA in Parkinson's disease have been related to dopamine transmission in the striatum. However, the putative involvement of serotonergic neurons in the dopaminergic effects Of L-DOPA suggests that the striatum is not a preferential target of L-DOPA. By using microdialysis in a rat model of Parkinson's disease, we found that L-DOPA (3-100 mg/kg) increased dopamine extracellular levels monitored simultaneously in four brain regions receiving serotonergic innervation: striatum, substantia nigra, hippocampus, prefrontal cortex. The increase was regionally similar at the lowest dose and 2-3 times stronger in the striatum at higher doses. Citalopram, a serotonin reuptake blocker, or the destruction of serotonergic fibers by 5,7-dihydroxytryptamine impaired L-DOPA-induced dopamine release in all regions. These data demonstrate that L-DOPA induces an ectopic release of dopamine due to serotonergic neurons. The new pattern of dopamine transmission created by L-DOPA may contribute to the benefit and side effects of L-DOPA. (C) 2010 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据